Blood Test for Cancer: Types, Uses, and What to Expect
Written by: Dr. Ananya Sharma, MD | Medically Reviewed by: Dr. Rajesh Kumar, MD | Last Updated: February 2026
At a Glance
- Sample Required: Blood (venipuncture)
- Fasting Rules: Not required for CBC or tumor markers; some specialized tests may require fasting
- Turnaround Time (TAT): 24–48 hours for routine tests; 7–14 days for molecular profiling
- Base Cost: [Insert Current 2026 Price]
Introduction
Blood tests are a cornerstone of cancer diagnosis and management. They help detect abnormalities, monitor treatment efficacy, and identify potential side effects. While no single blood test can definitively diagnose cancer, they provide critical clues that guide further investigation. This guide explains the most common blood tests used in oncology, their limitations, and the role of advanced molecular diagnostics.
Types of Blood Tests for Cancer
Several blood tests are routinely used in cancer care. Each serves a specific purpose, from assessing overall health to detecting tumor-specific markers.
Complete Blood Count (CBC)
The CBC measures red blood cells, white blood cells, and platelets. Abnormal levels may indicate bone marrow disorders, leukemia, or the effect of chemotherapy. It is a fundamental test for evaluating overall health.
Tumor Markers
Tumor markers are proteins or other substances produced by cancer cells or by the body in response to cancer. Common examples include PSA (prostate), CA-125 (ovarian), and CEA (colorectal). However, they are not specific to cancer and can be elevated in benign conditions. They are used for monitoring treatment response and recurrence, not for initial diagnosis.
Liver Function Tests (LFTs)
LFTs measure enzymes and proteins like ALT, AST, and bilirubin. Elevated levels may indicate liver involvement, either from primary liver cancer or metastasis. They are also used to monitor hepatotoxicity from cancer treatments.
C-Reactive Protein (CRP)
CRP is an acute-phase protein that rises with inflammation. While chronic inflammation is a risk factor for cancer, CRP alone is not diagnostic. It is sometimes used to assess disease activity or infection risk during treatment.
Advanced Molecular Diagnostics
Modern oncology increasingly relies on molecular tests that analyze DNA, RNA, or proteins to guide personalized treatment. These include:
- Next-Generation Sequencing (NGS): Identifies genetic mutations in tumor tissue or blood (liquid biopsy) to match targeted therapies.
- Circulating Tumor DNA (ctDNA): Detects tumor-derived DNA fragments in blood, enabling non-invasive monitoring of treatment response and minimal residual disease.
- Whole Exome Sequencing (WES): Analyzes the protein-coding regions of the genome to identify hereditary cancer syndromes or somatic mutations.
These tests are performed at ISO 9001 certified labs like DNA Labs India, ensuring high-quality results.
Information Gain: Blood Test Comparison
| Test | What It Measures | Common Use | Limitations |
|---|---|---|---|
| CBC | Red/white blood cells, platelets | Overall health, leukemia, chemo monitoring | Non-specific; many conditions affect counts |
| Tumor Markers | Proteins like PSA, CA-125, CEA | Treatment response, recurrence | Not diagnostic; false positives/negatives |
| LFTs | Liver enzymes, bilirubin | Liver cancer, metastasis, drug toxicity | Elevated in many non-cancer liver conditions |
| ctDNA (Liquid Biopsy) | Tumor DNA fragments in blood | Monitor mutations, minimal residual disease | May miss low-level disease; costlier |
Limitations and Clinical Context
Blood tests are not standalone diagnostic tools. A cancer diagnosis typically requires imaging (CT, MRI) and tissue biopsy for histopathological confirmation. Blood tests are most valuable when interpreted alongside clinical history and other investigations. Elevated markers can occur in benign conditions, and normal levels do not rule out cancer.
When to Consider a Blood Test
You may need a blood test if you experience unexplained weight loss, persistent fatigue, unusual bleeding, or a family history of cancer. However, routine screening is only recommended for specific cancers (e.g., PSA for prostate, CA-125 for high-risk ovarian). Always consult your physician to determine the appropriate tests based on your risk factors.
Conclusion
Blood tests play a vital role in cancer care, from initial evaluation to treatment monitoring. Advances in molecular diagnostics, such as NGS and ctDNA, have revolutionized precision oncology. At DNA Labs India, an ISO 9001 certified lab, we offer a range of blood tests to support your healthcare journey. Early detection saves lives—talk to your doctor about which tests are right for you.